These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37325521)
1. Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO Cheng FT; Geng YD; Liu YX; Nie X; Zhang XG; Chen ZL; Tang LQ; Wang LH; You YZ; Zhang L Nanoscale Adv; 2023 Jun; 5(12):3336-3347. PubMed ID: 37325521 [TBL] [Abstract][Full Text] [Related]
2. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy. Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813 [TBL] [Abstract][Full Text] [Related]
3. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy. Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225 [TBL] [Abstract][Full Text] [Related]
5. Disulfiram-loaded CuO Hu W; Yang L; Liao H; Sun D; Ouyang XK; Wang N; Yang G J Colloid Interface Sci; 2024 Nov; 674():9-18. PubMed ID: 38908062 [TBL] [Abstract][Full Text] [Related]
6. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation. Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072 [TBL] [Abstract][Full Text] [Related]
7. Enhanced Tumor-Specific Disulfiram Chemotherapy by Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050 [TBL] [Abstract][Full Text] [Related]
8. Smart Tumor Microenvironment-Responsive Nano-Prodrug for Disulfiram Toxification In Situ and the Exploration of Lethal Mechanisms in Cells. Zhang Y; Qi G; Qu X; Wang B; Ma K; Jin Y Langmuir; 2022 Jan; 38(1):584-592. PubMed ID: 34971310 [TBL] [Abstract][Full Text] [Related]
9. Self-supplying Cu Gao Y; Cai X; Zou W; Tang X; Jiang L; Hao J; Zheng Y; Ye X; Ying T; Li A RSC Adv; 2024 Apr; 14(19):13180-13189. PubMed ID: 38655468 [TBL] [Abstract][Full Text] [Related]
10. Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335 [TBL] [Abstract][Full Text] [Related]
11. A cascade nanoplatform for intelligent response to tumor microenvironment and collaborative cancer therapy. Li T; Rong M; Wang Y; Sun W; Lu L J Mater Chem B; 2024 Mar; 12(10):2537-2546. PubMed ID: 38345306 [TBL] [Abstract][Full Text] [Related]
12. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy. Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355 [TBL] [Abstract][Full Text] [Related]
13. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy. Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924 [TBL] [Abstract][Full Text] [Related]
14. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging. Ding Y; Huang Z; Luo Y; Lin H; Wang J; Zeng Z; Zhang T; Chen Y; Gong Y; Zhang M; Zhao C Acta Biomater; 2024 Oct; 187():316-327. PubMed ID: 39151666 [TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310 [TBL] [Abstract][Full Text] [Related]
16. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy. Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206 [TBL] [Abstract][Full Text] [Related]
17. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification. Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734 [TBL] [Abstract][Full Text] [Related]
18. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers. Chen W; Yang W; Chen P; Huang Y; Li F ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340 [TBL] [Abstract][Full Text] [Related]
19. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis. Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774 [TBL] [Abstract][Full Text] [Related]
20. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow. Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]